Skip to Content

'
Brian R. Weston, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Gastroenterology, Hepat,& Nutr, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Unit Number: 1466
Houston, TX 77030
Room Number: Unit 1466
Phone: 713-794-5073
Fax: 713-563-4408

Education & Training

Degree-Granting Education

1999 Royal College of Surgeons Ireland, Dublin, Ireland, MD, Medical School
1992 Tufts University, Medford, MA, BS, Undergraduate

Postgraduate Training

8/2007-7/2008 Clinical Fellowship / Clinical Instructor, Therapeutic Endoscopy, The University of Texas M. D. Anderson Cancer Center, Houston, TX
7/2004-6/2007 Clinical Fellowship, Gastroenterology, The University of Texas Health Science Center - M. D. Anderson Cancer Center, Houston, TX
7/2003-6/2004 Clinical Fellowship, Transplant Hepatology, Indiana University School of Medicine, Indianapolis, IN
7/2000-6/2003 Clinical Residency, Internal Medicine, Indiana University School of Medicine, Indianapolis, IN
7/1999-6/2000 Clinical Internship, Medicine and Surgery, Royal College of Surgeons - Beaumont Hospital, Dublin, Ireland

Board Certifications

10/2013 American Board of Internal Medicine - Internal Medicine
2/2009 Medical Council Ireland - Specialist Registration Gastroenterology
11/2008 American Board of Internal Medicine - Transplant Hepatology
10/2007 American Board of Internal Medicine - Gastroenterology

Professional Memberships

American College of Gastroenterology, Bethesda, MD
Member, 2007
American Gastroenterology Association, Bethesda, MD
Member, 2007
American Medical Association, Chicago, IL
Member, 2000
American Society for the Study of Liver Diseases, Alexandria, VA
Member, 2008
American Society of Gastrointestinal Endoscopy, Oak Brook, IL
Member, 2007
European Society of Gastrointestinal Endoscopy, Munich, Germany
Member, 2011
Texas Medical Association / Harris County Medical Society, Houston, TX
applied membership, 2012

Selected Publications

Peer-Reviewed Original Research Articles

1. Ajani JA, Wang X, Song S, Suzuki A, Taketa T,Sudo K, Wadhwa R, Hofstetter WL, Komaki R, Maru DM, Lee JH, Bhutani MS, Weston B, Baladandayuthapani V, Yao Y, Honjo S, Scott AW, Skinner HD, Johnson RL, Berry D. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Mol Oncol 8(1):142-9, 2/2014. e-Pub 10/2013.
2. Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, SKinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Locoregional Failure rate after preoperative chemoradiation of esophageal adenocarcinoma an the outcomes of salvage strategies. J Clin Oncol 31(34):4306-10, 12/2013. e-Pub 10/2013.
3. Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmus J, Swisher SG, Hofstetter WL, Ajani JA. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation. Ann Oncol 24(11):2854-9, 11/2013.
4. Wadhwa R, Taketa T, Correa AM, Sudo K, Campagna MC, Blum MA, Komaki R, Skinner H, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: Implications for screening and surveillance. Oncology 85(4):204-7, 9/2013.
5. Taketa T, Xiao L, Sudo K, Suzuki A, Wadhwa R, Blum MA, Lee JH, Weston B, Bhutani MS, Skinner H, Komaki R, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Propensity-based matching between esophagogastric cancer patients who had surgery and who declined surgery after preoperative chemoradiation. Oncology 85(2):95-9, 7/2013.
6. Suzuki R, Lee JH, Krishna SG, Ramireddy S, Qiao W, Weston B, Ross WA, Bhutani MS. Repeat endoscopic ultrasound-guided fine needle aspiration for solid pancreatic lesions at a tertiary referral center will alter the initial inconclusive result. J Gastrointestin Liver Dis 22(2):183-7, 6/2013.
7. Weston BR, Bhutani MS. Technical Review: Optimizing diagnostic yield for EUS-guided sampling of solid pancreatic lesions. Gastroenterology and Hepatology 9(6):35-63, 6/2013.
8. Krishna SG, Bhutani MS, Mosher CH, Staerkel GA, Weston BR. A first report of endoscopic ultrasound for the diagnosis of pancreatic amyloid deposition in immunoglobulin light chain (a1) amyloidosis (primary amyloidosis). JOP 14(3):283-5, 5/2013.
9. Buxbaum J, Ross W, tang SJ, Weston B, Raju GS, Eisen GM. Are clips useful in the prevention of delayed bleeding after endoscopic mucosal resection? Gastrointest Endosc 77(3):491.e2-491.e4, 3/2013.
10. Buxbaum J, Ross W, Tang SJ, Weston B, Raju GS, Eisen GM. Is there a difference in adenoma recurrence by race-ethnicity? Gastrointest Endosc 77(3):491.e2; 491 e.4-5, 3/2013.
11. Buxbaum J, Ross W, Tang SJ, Weston B, Raju GS, EIsen GM. Management for Patients with tubular adenoma. Gastrointest Endosc 77(3):491.e1; 491.e3, 3/2013.
12. Chen WC, Weston BR, Krishna SG, Gomez G, Rashid A, Katz MH, Lee JE, Raju GS. Prolonged endoloop ligation for removal of gastrointestinal tumors. Endoscopy 45(S(02)):E69-70, 3/2013.
13. Buxbaum J, Ross W, Tang SJ, Weston B, Raju GS, Eisen GM. Surveillance colonoscopy in patients with a serrated polyp. Gastrointest Endosc 77(3):491.e1; 491.e3-4, 3/2013.
14. Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer. Eur J Cancer 48(18):3396-404, 12/2012.
15. Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A Jr, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized gastric cancer treated with chemoradiation without surgery: UTMD Anderson Cancer Center experience. Oncology 82(6):347-51, 10/2012.
16. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery After Preoperative Chemoradiation. Oncology. 83(5):300-4, 9/2012.
17. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, Ajani JA. Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology 82(2):108-13, 2/2012.
18. Weston BR. Mediastinal paraganglioma: EUS findings and a cautious reminder of potential risks from FNA of unknown mediastinal masses. Visible Human Journal of Endoscopy 11(2), 2012.
19. Weston BR, Ross WA, Liu J, Lee JH. Clinical outcomes of nitinol and stainless steel uncovered metal stents for malignant biliary strictures: is there a difference? Gastrointestinal Endoscopy 72(6):1195-200, 12/2010. PMID: 21111871.
20. Weston BR, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer 116(6):1454-61, 3/2010. PMID: 20143447.
21. Weston BR, Thosani , Bektas M, Oruc N, Butani MS. Pill esophagitis masquerading as esophageal cancer on endoscopy and endoscopic ultrasound. Visible Human Journal of Endoscopy 2010;9(2) 9(2), www.vhjoe.org, 2010.
22. Weston BR, Bhutani MS. Metastatic recurrent appendiceal adenocarcinoma to the peritoneum diagnosed by rectal endoscopic ultrasound. Visible Human Journal of Endoscopy 8(1), www.vhjoe.com, 2009.
23. Weston BR, Ross WA, Wolff RA, Evans D, Lee JE, Wang X, Xiao LC, Lee JH. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography? Cancer 112(11):2417-23, 6/2008. PMID: 18404695.
24. Weston BR, Anandasabathy S, Bhutani MS. Splenule masquerading as pancreatic neuroendocrine tumor. Visible Human Journal of Endoscopy 7(2), www.vhjoe.com, 2008.
25. Weston BR, Chadalawada V, Chalasani N, Kwo P, Overley CA, Symms M, Strahl E, Rex DK. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients. American Journal of Gastroenterology 98(11):2440-7, /www.nature.com/ajg/journal, 11/2003. PMID: 14638346.
26. Weston BR, Helper DJ, Rex DK. Positive predictive value of endoscopic features deemed typical of gastric fundic gland polyps. J Clin Gastroenterol 36(5):399-402, May-Jun, 5/2003. PMID: 12702980.

Book Chapters

1. Weston BR, Ko C. Biliary tract disease in pregnancy. In: Complications of Pregnancy, 6th. Ed(s) Cohen WR, August P. PMPH-USA Ltd. Shelton, CT, 2013.
2. Manoop S. Bhutani, John C. Deutsch. Endoscopic Ultrasound (EUS) in Inflammatory Bowel Disease (IBD). In: EUS Pathology with Digital Anatomy Correlation. People's Medical Publishing House: Shelton, Connecticut, 397-400, 2010.
3. Brian R. Weston, M.D., Manoop S. Bhutani, M.D. Ovarian and Gynecological Lesions. In: EUS Pathology with Digital Anatomy Correlation. People's Medical Publishing House: Shelton, Connecticut, 369-374, 2010.

Last updated: 1/23/2014